Literature DB >> 32192836

The Lawrence D. Dorr Surgical Techniques & Technologies Award: Aseptic Reoperations Within One Year of Primary Total Hip Arthroplasty Markedly Increase the Risk of Later Periprosthetic Joint Infection.

Ashton H Goldman1, Douglas R Osmon1, Arlen D Hanssen1, Mark W Pagnano1, Daniel J Berry1, Matthew P Abdel1.   

Abstract

BACKGROUND: Despite the success of primary total hip arthroplasties (THAs), some patients will require an aseptic reoperation within 1 year of the index THA. The goal of this study is to evaluate the risk of subsequent periprosthetic joint infection (PJI) in patients undergoing an aseptic reoperation within 1 year of a primary THA.
METHODS: A retrospective review utilizing our institutional joint registry identified 211 primary THAs requiring aseptic reoperation within 1 year following index arthroplasty. A control group of 15,357 primary THAs not requiring reoperation within 1 year was identified. Patients were divided into groups based on time from primary THA to reoperation: (1) within 90 days (n = 112 THAs; 40% for dislocation, 34% for periprosthetic fracture) or (2) 91-365 days (n = 99 THAs; 37% for dislocation, 29% for periprosthetic fracture). Mean follow-up was 7 years.
RESULTS: Patients undergoing an aseptic reoperation within 90 days had a PJI rate of 4.8% at 2 years, while the 91-365 day group had a PJI rate of 3.2% at 2 years. The control group had a PJI rate of 0.2% at 2 years. Employing a multivariate analysis, reoperation within 90 days of index arthroplasty had an elevated risk of PJI (hazard ratio 8, P < .001) as did a reoperation between 91 and 365 days (hazard ratio 13, P < .001).
CONCLUSION: Aseptic reoperations within 1 year following primary THA resulted in an 8- to 13-fold increased risk of subsequent PJI. The risk was similar whether the aseptic reoperation was early (within 90 days) or later (91-365 days). LEVEL OF EVIDENCE: Level III (Prognostic).
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aseptic reoperations; dislocation; periprosthetic fracture; periprosthetic joint infection; total hip arthroplasty

Mesh:

Year:  2020        PMID: 32192836     DOI: 10.1016/j.arth.2020.02.054

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  4 in total

1.  Novel Coronavirus and Orthopaedic Surgery: Early Experiences from Singapore.

Authors:  Zhen Chang Liang; Wilson Wang; Diarmuid Murphy; James Hoi Po Hui
Journal:  J Bone Joint Surg Am       Date:  2020-05-06       Impact factor: 5.284

2.  Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.

Authors:  Temet M McMichael; Dustin W Currie; Shauna Clark; Sargis Pogosjans; Meagan Kay; Noah G Schwartz; James Lewis; Atar Baer; Vance Kawakami; Margaret D Lukoff; Jessica Ferro; Claire Brostrom-Smith; Thomas D Rea; Michael R Sayre; Francis X Riedo; Denny Russell; Brian Hiatt; Patricia Montgomery; Agam K Rao; Eric J Chow; Farrell Tobolowsky; Michael J Hughes; Ana C Bardossy; Lisa P Oakley; Jesica R Jacobs; Nimalie D Stone; Sujan C Reddy; John A Jernigan; Margaret A Honein; Thomas A Clark; Jeffrey S Duchin
Journal:  N Engl J Med       Date:  2020-03-27       Impact factor: 91.245

3.  Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection.

Authors:  Shaoqing Lei; Fang Jiang; Wating Su; Chang Chen; Jingli Chen; Wei Mei; Li-Ying Zhan; Yifan Jia; Liangqing Zhang; Danyong Liu; Zhong-Yuan Xia; Zhengyuan Xia
Journal:  EClinicalMedicine       Date:  2020-04-05

4.  Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People's Republic of China.

Authors:  Xiaodong Guo; Jiedong Wang; Dong Hu; Lisha Wu; Li Gu; Yang Wang; Jingjing Zhao; Lian Zeng; Jianduan Zhang; Yongchao Wu
Journal:  J Bone Joint Surg Am       Date:  2020-05-20       Impact factor: 6.558

  4 in total
  1 in total

1.  Early aseptic reoperation after shoulder arthroplasty increases risk of subsequent prosthetic joint infection.

Authors:  John R Wickman; Daniel E Goltz; Jay M Levin; Tally Lassiter; Oke A Anakwenze; Christopher S Klifto
Journal:  JSES Int       Date:  2021-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.